Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on May 23, 2022, by Cellectis S.A., a foreign private issuer based in Paris, France, serves to announce the scheduling of the Company's Combined General Meeting of Shareholders. The filing does not contain financial results or operational updates for a specific reporting period.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not include financial statements.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document solely communicates the date, time, and location of the upcoming shareholder meeting.
Guidance, Outlook, and Risks
There is no management commentary, financial guidance, or discussion of risks and contingencies in this specific filing. The text incorporates by reference the Notice of Combined Shareholders' Meeting (Exhibit 99.1), which contains the text of resolutions to be voted upon.
Key Facts for Investors
- Meeting Date: June 28, 2022.
- Meeting Time: 2:30 p.m. Paris time.
- Meeting Location: 8, rue de la Croix Jarry, 4th floor, 75013 Paris, France.
- Document Type: Notice of Combined General Meeting of Shareholders.
- Signatory: André Choulika, Chief Executive Officer.